Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Merlo

Showing results (401-410 of 432) with videos related to

Pageof 44
Sort By:
Journal of the American College of Cardiology|December 3, 2016
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic CardiomyopathiesMartín F Ortiz-Genga, Sofía Cuenca, Matteo Dal Ferro, et al.
European Journal of Heart Failure|January 12, 2020
Viral genome search in myocardium of patients with fulminant myocarditisGiacomo Veronese, Enrico Ammirati, Michela Brambatti, et al.
European Journal of Preventive Cardiology|September 9, 2021
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE StudyMarco Merlo, Aldostefano Porcari, Linda Pagura, et al.
Journal of Cardiovascular Translational Research|July 7, 2023
A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy PatientsEmilia Nagyova, Edgar T Hoorntje, Wouter P Te Rijdt, et al.
Journal of the American College of Cardiology|September 15, 2022
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated CardiomyopathyLuis Escobar-Lopez, Juan Pablo Ochoa, Ana Royuela, et al.
Circulation. Heart Failure|September 24, 2025
Sex Differences in Prognosis of Patients With Genetic Dilated CardiomyopathySophie L V M Stroeks, Marco Merlo, Nerea Mora-Ayestaran, et al.
European Journal of Heart Failure|April 13, 2022
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide surveyMarco Merlo, Linda Pagura, Aldostefano Porcari, et al.
JACC. Advances|June 28, 2024
Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular CardiomyopathyAlessio Gasperetti, Richard Carrick, Alexandros Protonotarios, et al.
ESC Heart Failure|September 20, 2024
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND studyGiacomo Tini, Beatrice Musumeci, Paolo Milani, et al.
Journal of the American College of Cardiology|May 20, 2026
Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe RegistrySophie L V M Stroeks, Nicole K Bart, Joseph Rossano, et al.
Pageof 44

Showing results (401-410 of 432) with videos related to

Sort By:
Pageof 44
Journal of the American College of Cardiology|December 3, 2016
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic CardiomyopathiesMartín F Ortiz-Genga, Sofía Cuenca, Matteo Dal Ferro, et al.
European Journal of Heart Failure|January 12, 2020
Viral genome search in myocardium of patients with fulminant myocarditisGiacomo Veronese, Enrico Ammirati, Michela Brambatti, et al.
European Journal of Preventive Cardiology|September 9, 2021
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE StudyMarco Merlo, Aldostefano Porcari, Linda Pagura, et al.
Journal of Cardiovascular Translational Research|July 7, 2023
A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy PatientsEmilia Nagyova, Edgar T Hoorntje, Wouter P Te Rijdt, et al.
Journal of the American College of Cardiology|September 15, 2022
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated CardiomyopathyLuis Escobar-Lopez, Juan Pablo Ochoa, Ana Royuela, et al.
Circulation. Heart Failure|September 24, 2025
Sex Differences in Prognosis of Patients With Genetic Dilated CardiomyopathySophie L V M Stroeks, Marco Merlo, Nerea Mora-Ayestaran, et al.
European Journal of Heart Failure|April 13, 2022
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide surveyMarco Merlo, Linda Pagura, Aldostefano Porcari, et al.
JACC. Advances|June 28, 2024
Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular CardiomyopathyAlessio Gasperetti, Richard Carrick, Alexandros Protonotarios, et al.
ESC Heart Failure|September 20, 2024
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND studyGiacomo Tini, Beatrice Musumeci, Paolo Milani, et al.
Journal of the American College of Cardiology|May 20, 2026
Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe RegistrySophie L V M Stroeks, Nicole K Bart, Joseph Rossano, et al.
Pageof 44